Dow Down 1.40% Nasdaq Down 1.59%

Lpath Inc. (LPTN)

-NasdaqCM
3.50 Down 0.02(0.57%) Oct 1, 4:00PM EDT
Prev Close:3.52
Open:3.50
Bid:3.45 x 3000
Ask:3.51 x 700
1y Target Est:14.00
Beta:0.39
Next Earnings Date:N/A
Day's Range:3.41 - 3.57
52wk Range:2.75 - 5.68
Volume:159,494
Avg Vol (3m):40,253
Market Cap:54.66M
P/E (ttm):N/A
EPS (ttm):-0.77
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for LPTN

Key Statistics

Forward P/E (1 yr):87.50
P/S (ttm):6.95
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.13
Quarterly EPS Est (Sep-14) :-0.33
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Lpath, Inc., a biotechnology company, focuses on the discovery and development of lipidomic-based therapeutic antibodies for treating a range of human diseases primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback